Ignite Creation Date:
2024-05-06 @ 2:51 PM
Last Modification Date:
2024-10-26 @ 1:38 PM
Study NCT ID:
NCT04442581
Status:
TERMINATED
Last Update Posted:
2023-04-05
First Post:
2020-06-18
Brief Title:
Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer
Sponsor:
University of Washington
Organization:
University of Washington
Organization Data
Organization:
University of Washington
Class:
OTHER
Study ID:
RG1007034
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Washington
Lead Sponsor Class:
OTHER
Responsible Party:
Gentry George King
Responsible Party Title:
Assistant Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Washington
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Exelixis | INDUSTRY |